HPTN Publications

Janssen RS, Satten GA, Stramer SL, Rawal BD, O'Brien TR, Weiblen BJ, Hecht FM, Jack N, Cleghorn FR, Kahn JO, Chesney MA, Busch MP . New testing strategy to detect early HIV-1 infection for use in incidence estimates and for clinical and prevention purposes. JAMA. 1998, 280: 42-48

Jasmine Abrams . Longitudinal associations between incarceration and substance use, sexual risk-taking, and STI in a sample of Black men who have sex with men: Evaluation of cohort differences by age. 2020

Jason E. Farley, Geetha Beuchamp, Alanna J. Bergman, James P. Hughes, D. Scott Batey, Carlos del Rio, Julia Raifman, Kelly Lowensen, Theresa Gamble, Robert H. Remien, Chris Beyrer . The impact of stigma and sexual identity on PrEP awareness and use among at-risk men who have sex with men in four U.S. cities (HPTN 078). Stigma and Health. Advance online publication.. Stigma Health. 2024, 9: 400-410

Jennings L, Pettifor A, Hamilton E, Ritchwood TD, Xavier Gomez-Olive F, MacPhail C, Hughes JP, Selin A, Kahn K, HPTN 068 Study Team . Economic Resources and HIV Preventive Behaviors Among School-Enrolled Young Women in Rural South Africa (HPTN 068). AIDS Behav. 2017, 21: 665-677

Jennings L, Rompalo AM, Wang J, Hughes J, Adimora AA, Hodder S, Soto-Torres LE, Frew PM, Haley DF; HIV Prevention Trials Network (HPTN 064) Women’s HIV SeroIncidence Study (ISIS), Haley DF, HIV Prevention Trials Network (HPTN 064) Women’s HIV SeroIncidence Study (ISIS), HIV Prevention Trials Network (HPTN 064) Women’s HIV SeroIncidence Study . Prevalence and Correlates of Knowledge of Male Partner HIV Testing and Serostatus Among African-American Women Living in High Poverty, High HIV Prevalence Communities (HPTN 064). AIDS Behav. 2015, 19: 291-301

Jeremy Sugarman, Deborah J Donnell, Brett Hanscom, Marybeth McCauley, Beatriz Grinsztejn, Raphael J Landovitz, Sugarman J, Donnell DJ, Hanscom B, McCauley M, Grinsztejn B, Landovitz RJ . Ethical issues in establishing the efficacy and safety of long-acting injectable pre-exposure prophylaxis for HIV prevention: the HPTN 083 trial. Lancet HIV. 2021, 8: e723-e728

Joglekar N, Joshi S, Kakde M, Fang G, Cianciola M, Reynolds S, Mehendale S; HIV Prevention Trial Network 047 Protocol Team . Acceptability of PRO2000 vaginal gel among HIV un-infected women in Pune, India. AIDS Care. 2007, 19: 817-21 PMID: 17573603

John GC, Sheppard H, Mbori-Ngacha D, Nduati R, Maron D, Reiner M, Kreiss J . Comparison of techniques for HIV-1 RNA detection and quantitation in cervicovaginal secretions. J Acquir Immune Defic Syndr. 2001, 26: 170-5